SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-282586
Filing Date
2022-11-10
Accepted
2022-11-10 16:06:45
Documents
4
Period of Report
2022-12-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d327928ddef14a.htm DEF 14A 253521
2 GRAPHIC g327928g22a01.jpg GRAPHIC 41949
3 GRAPHIC g327928g44a01.jpg GRAPHIC 138908
4 GRAPHIC g327928g44a02.jpg GRAPHIC 122062
  Complete submission text file 0001193125-22-282586.txt   658044
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36912 | Film No.: 221377086
SIC: 2836 Biological Products, (No Diagnostic Substances)